TipRanks on MSN

Sino Biopharm’s oral psoriasis drug TQH3906 delivers biologic-like efficacy in phase II trial

Sino Biopharmaceutical ( ($HK:1177) ) has provided an update. Sino Biopharmaceutical has reported positive Phase II clinical trial results for ...

InnoCare Announces NMPA Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Cutaneous Lupus Erythematosus

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and ...
C&EN

Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. Article Views are the COUNTER-compliant sum of full text article downloads since ...
IEEE

A Comprehensive Survey on Source-Free Domain Adaptation

Abstract: Over the past decade, domain adaptation has become a widely studied branch of transfer learning which aims to improve performance on target domains by leveraging knowledge from the source ...
C&EN

Optogenetic Analysis of Allosteric Control in Protein Tyrosine Phosphatases

Department of Chemical and Biological Engineering, University of Colorado−Boulder, 3415 Colorado Avenue, Boulder, Colorado 80303, United States *Department of Chemical and Biological Engineering, ...